Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Xagrid (anagrelide hydrochloride) - Important Safety Information from Shire as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
04/02/2013
Problem Or Issue:
Important Safety Information communication from Shire on cardiovascular risk in patients with essential thrombocythaemia (ET) associated with Xagrid (anagrelide hydrochloride).
Important Safety Information - Xagrid (anagrelide hydrochloride)
« Back
Date Printed: 28/04/2024